Recent advances in the genetics of rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 22, Issue 2, 2010, Pages 109-118

  Raychaudhuri, Soumya ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Association study; Genetics; Genomics; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2;

GENETIC DISORDER; GENETIC RISK; GENOME ANALYSIS; HUMAN; IMMUNOPATHOGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RELATIVE; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS;

ALLELES; ARTHRITIS, RHEUMATOID; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TWIN STUDIES AS TOPIC;

EID: 75749099775     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328336474d     Document Type: Review

References (75)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-361.
2. Isenberg D. Oxford textbook of rheumatology. 3rd edn. Oxford: New York: Oxford University Press; 2004.
3. Heberden W. Commentaries on the history and cure of diseases. 3rd edn. London: Printed for T. Payne; 1806.
4. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205-1213.
5. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298:869-871.
6. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62:835-841.
7. Remmers EF, Longman RE, Du Y, et al. A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nat Genet 1996; 14:82-85.
8. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001; 2:802-809.
9. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10:4025-4031.
10. Williams RO, Feldmann M, Maini RN. Antitumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89:9784-9788.
11. Hart JE, Laden F, Puett RC, et al. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect 2009; 117:1065-1069.
12. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42:1071-1079.
13. Lewis-Faning E. Report on an enquiry into the aetiological factors associated with rheumatoid arthritis. Ann Rheum Dis 1950; 9:1-94.
14. Lawrence JS. Heberden Oration, 1969. Rheumatoid arthritis: nature or nurture? Ann Rheum Dis 1970; 29:357-379.
15. del Junco D, Luthra HS, Annegers JF, et al. The familial aggregation of rheumatoid arthritis and its relationship to the HLA-DR4 association. Am J Epidemiol 1984; 119:813-829.
16. Jones MA, Silman AJ, Whiting S, et al. Occurrence of rheumatoid arthritis is not increased in the first degree relatives of a population based inception cohort of inflammatory polyarthritis. Ann Rheum Dis 1996; 55:89-93.
17. Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009; 60:661-668.
18. Lynn AH, Kwoh CK, Venglish CM, et al. Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet 1995; 57:150-159.
19. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43:30-37.
20. Aho K, KoskenvuoM,Tuominen J, KaprioJ. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986; 13:899-902.
21. Silman AJ, MacGregor AJ, Thomson W, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32:903-907.
22. Svendsen AJ, HolmNV, KyvikK, et al. Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ 2002; 324:264-266.
23. van der Woude D, Houwing-Duistermaat JJ, Toes RE, et al. Quantitative heritability of anticitrullinated protein antibody-positive and anticitrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 2009; 60:916-923.
24. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007; 39:1477-1482.
25. Orozco G, Hinks A, Eyre S, et al. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum Mol Genet 2009; 18:2693-2699.
26. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis: a genomewide study. N Engl J Med 2007; 357:1199-1209.
27. Kurreeman FA, Padyukov L, Marques RB, et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007; 4:e278.
28. Gregersen PK, Amos CI, Lee AT, etal. REL, encoding a member of the NF-KB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009; 41:820-823.
29. Barton A, Thomson W, Ke X, et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15,12q13 and 22q13. Nat Genet 2008; 40:1156-1159.
30. Plenge RM, Padyukov L, Remmers EF, etal. Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4,and PADI4. Am J Hum Genet 2005; 77:1044-1060.
31. Zhernakova A, Alizadeh BZ, Bevova M, et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007; 81:1284-1288.
32. Barton A, Eyre S, Ke X, et al. Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes. Hum Mol Genet 2009; 18:2518-2522.
33. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75:330-337.
34. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357:977-986.
35. Suzuki A, Yamada R, Kochi Y, et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat Genet 2008; 40:1224-1229.
36. Raychaudhuri S, Thomson BP, Remmers EF, etal. Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009; 41:1313-1318.
37. Thomson W, Barton A, Ke X, etal. Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39:1431-1433.
38. Kurreeman FA, Daha NA, Chang M, et al. Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population. Ann Rheum Dis 2009; 68:1789-1790.
39. Raychaudhuri S, Remmers EF, Lee AT, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40:1216-1223.
40. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34:395-402.
41. Kochi Y, Yamada R, Suzuki A, etal. Afunctional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005; 37:478-485.
42. Halushka MK, Fan JB, Bentley K, et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 1999; 22:239-247.
43. Cargill M, Altshuler D, Ireland J, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22:231-238.
44. Wang DG, Fan JB, Siao CJ, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280:1077-1082.
45. Matsuzaki H, Loi H, Dong S, et al. Parallel genotyping of over 10 000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 2004; 14:414-425.
46. Shen R, Fan JB, Campbell D, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res 2005; 573:70-82.
47. Bhangale TR, Rieder MJ, Nickerson DA. Estimating coverage and power for genetic association studies using near-complete variation data. Nat Genet 2008; 40:841-843.
48. de Bakker PI, Yelensky R, Pe'er I, et al. Efficiency and power in genetic association studies. Nat Genet 2005; 37:1217-1223.
49. The Wellcome Trust. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
50. Marchini J, Howie B, Myers S, etal. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39:906-913.
51. de Bakker PI, Ferreira MA, Jia X, etal. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 2008; 17:R122-R128.
52. Orozco G, Eyre S, Hinks A, et al. Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study. Ann Rheum Dis 2009.
53. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40:955-962.
54. Lettre G, Jackson AU, Gieger C, etal. Identification often loci associated with height highlights new biological pathways in human growth. Nat Genet 2008; 40:584-591.
55. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008; 40:638-645.
56. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10:43-55.
57. Coenen MJ, Trynka G, Heskamp S, et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009; 18:4195-4203.
58. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-338.
59. Raychaudhuri S, Plenge RM, Rossin EJ, Ng ACY; International Schizophrenia Consortium, Purcell SM, Sklar P, Scolnick EM, etal. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLOS Genet 2009; 5:e1000534.
60. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. The contribution of HLAto rheumatoid arthritis. Clin Genet 1989; 36:178-182.
61. Lee HS, Lee AT, Criswell LA, et al. Several regions in the major histocompat-ibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med 2008; 14:293-300.
62. Ding B, Padyukov L, Lundstrom E, etal. Different patterns of associations with anticitrullinated protein antibody-positive and anticitrullinated protein anti body-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009; 60:30-38.
63. Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 2008; 82: 48-56.
64. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38:1166-1172.
65. McCarroll SA, Kuruvilla FG, Korn JM, et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008; 40:1253-1260.
66. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444:444-454. (Pubitemid 44809057)
67. Alkan C, Kidd JM, Marques-Bonet T, et al. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 2009; 41:1061-1067.
68. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008; 40:1107-1112.
69. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008; 40:23-25.
70. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008; 455:232-236.
71. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455:237-241.
72. Prahalad S. Negative association between the chemokine receptor CCR5-delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 2006; 7:264-268.
73. McKinney C, Merriman ME, Chapman PT, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008; 67:409-413.
74. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anticyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54:1117-1121.
75. Karlson EW, Chibnik LB, Kraft P, et al. Cumulative association of twenty-two genetic variants with seropositive rheumatoid arthritis risk. Ann Rheum Dis (in press).